Interprotein Corporation(製薬・医療分野):企業M&A動向

◆英語タイトル:Interprotein Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH194320D
◆発行会社(調査会社):GlobalData
◆発行日:2015年3月25日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Summary

Interprotein Corporation (Interprotein) is a drug discovery company. The company research and develops small molecule drugs based on protein interactions. Its products include VEGF inhibitor, IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitor and zinc chelator. Interprotein’s IL-6 inhibitor is designed to treat Castleman’s disease, rheumatoid arthritis and juvenile idiopathic arthritis, cachexia and various kinds of inflammatory and autoimmune diseases; and IgE inhibitor is used in the treatment of asthma, allergic dermatitis, and pollinosis. The company’s VEGE inhibitor is used in therapy of various advanced cancers, adjuvant therapies and prevention of metastasis. It uses interprotein platform technology. Interprotein is headquartered in Kita-ku, Osaka, Japan.

Interprotein Corporation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Interprotein Corporation, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Interprotein Corporation, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Interprotein Enters Into Agreement With Takeda Pharma For PPI Inhibitors 10
RaQualia Pharma Enters Into Research Agreement With Interprotein For PPI Inhibitor 11
Interprotein Enters Into Co-Development Agreement With Takeda Pharma 12
LegoChem Biosciences Enters Into Collaboration Agreement With Interprotein 13
Interprotein Enters Into Drug Discovery Agreement With Ajinomoto Pharma 14
Interprotein Corporation – Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Interprotein Corporation, Pharmaceuticals & Healthcare, Key Facts 1
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Interprotein Corporation, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Interprotein Corporation, Deals By Therapy Area, 2009 to YTD 2015 8
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Interprotein Enters Into Agreement With Takeda Pharma For PPI Inhibitors 10
RaQualia Pharma Enters Into Research Agreement With Interprotein For PPI Inhibitor 11
Interprotein Enters Into Co-Development Agreement With Takeda Pharma 12
LegoChem Biosciences Enters Into Collaboration Agreement With Interprotein 13
Interprotein Enters Into Drug Discovery Agreement With Ajinomoto Pharma 14
Interprotein Corporation, Key Competitors 15
Interprotein Corporation, Key Employees 16
Interprotein Corporation, Other Locations 17

List of Figures
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Interprotein Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

★調査レポート[Interprotein Corporation(製薬・医療分野):企業M&A動向] (コード:GDPH194320D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Interprotein Corporation(製薬・医療分野):企業M&A動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆